Logo image of ALEO2.PA

EO2 (ALEO2.PA) Stock Fundamental Analysis

Europe - EPA:ALEO2 - FR0010465534 - Common Stock

2.88 EUR
+0.08 (+2.86%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALEO2 gets a fundamental rating of 2 out of 10. We evaluated ALEO2 against 62 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALEO2 had negative earnings in the past year.
In the past year ALEO2 had a positive cash flow from operations.
ALEO2 had positive earnings in 4 of the past 5 years.
Of the past 5 years ALEO2 4 years had a positive operating cash flow.
ALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ALEO2 has a worse Return On Assets (-0.23%) than 77.42% of its industry peers.
With a Return On Equity value of -0.46%, ALEO2 is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.23%
ROE -0.46%
ROIC N/A
ROA(3y)3.69%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ALEO2.PA Yearly ROA, ROE, ROICALEO2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

The Gross Margin of ALEO2 (55.94%) is better than 67.74% of its industry peers.
ALEO2's Gross Margin has improved in the last couple of years.
ALEO2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
ALEO2.PA Yearly Profit, Operating, Gross MarginsALEO2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

ALEO2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALEO2 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.
Compared to 1 year ago, ALEO2 has an improved debt to assets ratio.
ALEO2.PA Yearly Shares OutstandingALEO2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ALEO2.PA Yearly Total Debt VS Total AssetsALEO2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

ALEO2 has an Altman-Z score of 1.58. This is a bad value and indicates that ALEO2 is not financially healthy and even has some risk of bankruptcy.
ALEO2 has a Altman-Z score (1.58) which is in line with its industry peers.
A Debt/Equity ratio of 0.36 indicates that ALEO2 is not too dependend on debt financing.
The Debt to Equity ratio of ALEO2 (0.36) is better than 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACC6.07%
ALEO2.PA Yearly LT Debt VS Equity VS FCFALEO2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

ALEO2 has a Current Ratio of 2.17. This indicates that ALEO2 is financially healthy and has no problem in meeting its short term obligations.
ALEO2 has a better Current ratio (2.17) than 82.26% of its industry peers.
A Quick Ratio of 1.49 indicates that ALEO2 should not have too much problems paying its short term obligations.
ALEO2 has a better Quick ratio (1.49) than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.49
ALEO2.PA Yearly Current Assets VS Current LiabilitesALEO2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -127.07% in the last year.
ALEO2 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.49%.
ALEO2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.28% yearly.
EPS 1Y (TTM)-127.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.96%
Revenue 1Y (TTM)-11.49%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%-2.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEO2.PA Yearly Revenue VS EstimatesALEO2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ALEO2.PA Yearly EPS VS EstimatesALEO2.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0.1 0.2 0.3 0.4 0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALEO2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEO2.PA Price Earnings VS Forward Price EarningsALEO2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALEO2 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.14
ALEO2.PA Per share dataALEO2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALEO2!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EO2

EPA:ALEO2 (10/3/2025, 7:00:00 PM)

2.88

+0.08 (+2.86%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners28.33%
Ins Owner ChangeN/A
Market Cap6.91M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF 3.73
P/B 0.34
P/tB 0.37
EV/EBITDA 7.14
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)0.77
OCFY26.82%
SpS12.57
BVpS8.41
TBVpS7.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.94%
FCFM N/A
ROA(3y)3.69%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 3.66
Cap/Depr 79.15%
Cap/Sales 9.19%
Interest Coverage N/A
Cash Conversion 92.89%
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.49
Altman-Z 1.58
F-Score5
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)115.4%
Cap/Depr(5y)96.64%
Cap/Sales(3y)8.27%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-159.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.49%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%-2.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-472.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y170.07%
OCF growth 3Y-29.12%
OCF growth 5Y-11.3%